With the metabolic syndrome driving
the twin global epidemics of type 2
diabetes and CVD there is an
overwhelming moral, medical and
economic imperative to identify those
individuals with metabolic syndrome
early, so that lifestyle interventions
and treatment may prevent the
development of diabetes and/or
cardiovascular disease.